Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Human iPS cells have been generated using a diverse range of tissues from a variety of donors using different reprogramming vectors. However, these cell lines are heterogeneous, which presents a limitation for their use in disease modeling and personalized medicine. To explore the basis of this heterogeneity we generated 25 iPS cell lines under normalised conditions from the same set of somatic tissues across a number of donors. RNA-seq data sets from each cell line were compared to identify the majority contributors to transcriptional heterogeneity. We found that genetic differences between individual donors were the major cause of transcriptional variation between lines. In contrast, residual signatures from the somatic cell of origin, so called epigenetic memory, contributed relatively little to transcriptional variation. Thus, underlying genetic background variation is responsible for most heterogeneity between human iPS cell lines. We conclude that epigenetic effects in hIPSCs are minimal, and that hIPSCs are a stable, robust and powerful platform for large-scale studies of the function of genetic differences between individuals. Our data also suggest that future studies using hIPSCs as a model system should focus most effort on collection of large numbers of donors, rather than generating large numbers of lines from the same donor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Genetic effects on transcription in iPSCs. (a) Variance component of known eQTL genes showing primary eQTL SNPs being able to explain 17% of FPKM variation on average. Top and bottom 3,000 eQTL genes and SNPs were determined by means of P-values using gEUVADIS RNA-seq data [27]. (b) Box- plot of log2 FPKM aggregated across 462 eQTL genes (FDR 5%) stratified into high (+/+), medium (+/−) and low (−/−) genotypes at the minimum p-value eQTL SNPs ascertained from [2] (FDR 5%). Pearson correlation r = 0.44, p<9.8×10−68. (c) Boxplot of allelic imbalance at high-expression (+) and low-expression (−) haplotypes across all eQTL genes ascertained from [2]. The red line is at 0.5 indicating the expected fraction under the null. Student t p<1.3×10−8. (d) Mean RNA-Seq coverage depth in iPSCs, averaged across all iPSC lines from each individual, at a putative example eQTL for the noncoding RNA SNHG5 gene. Individuals are grouped by their genotype at the putatively causal variant rs1059307. Individual genotypes are shown with the number of RNA-seq samples in parentheses. (e) Average coverage depth of fragments coming from the high-expression haplotype (allele T) and low- expression haplotype (allele G) at rs1059307. (f) eQTL association of SNHG5 gene at rs1059307 in lymphoblastoid cell lines from [2] showing distributions of log2 FPKM against SNP genotypes at rs1059307. The red line shows the best-fit linear regression line.](https://figures.cochat.ai/paper-figures/96597e1d7aa9463aababb4bb7d7946f0/genetic-background-drives-transcriptional-variation-in-human-induced-pluripotent-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reprogramming, for example, a given somatic cell type from a given donor, using a given reprogramming method and culture platform, may give rise to iPSC colonies that are different in their expansion rate, robustness (the tendency to spontaneously differentiate in culture), and potential to be differentiated directly to specific lineages [56,57,58,59,60].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Nevertheless, keeping the above parameters the same still results in iPSC colonies that are different from each other.”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · cited 2×
“We mapped reads to assembly h37 of the human genome using Bowtie2 [14] and constructed spliced alignments using Tophat2 [15].”
MethodInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · cited 1×
“We mapped reads to assembly h37 of the human genome using Bowtie2 [14] and constructed spliced alignments using Tophat2 [34] with default settings.”
MethodTopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248 · cited 1×
“Principal component analysis was performed using Eigenstrat [35] with genome-wide SNP genotypes of European populations obtained from 1000 Genomes Project.”
MethodEpigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313 · cited 1×
“We note, however, that other studies that have also explicitly controlled for genetic background still report some variation in transcription, methylation and differentiation efficiencies that appear to arise from cell type of origin effects [5,8,10].”
ResultTranscriptome and genome sequencing uncovers functional variation in humans
The Geuvadis Consortium, Lappalainen, T., Sammeth, M., Friedländer, M. R., ‘t Hoen, P. A. C., Monlong, J., Rivas, M. A., Gonzàlez-Porta, M., Kurbatova, N., Griebel, T., et al. (2013) · Nature · doi:10.1038/nature12531 · Cited by 1,888 · cited 2×
“Top and bottom 3,000 eQTL genes and SNPs were determined by means of P-values using gEUVADIS RNA-seq data [27].”
MethodBrowning, B. L., & Browning, S. R. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.01.005 · Cited by 1,640 · cited 2×
“5-8 BeadChip, followed by imputation with the 1000 Genomes Project data and haplotype phasing using Beagle software [5].”
Method
Cited by
Items 101–200 of 299
Saito, A. M., Ooki, A., Nakamura, T., Onodera, S., Hayashi, K., Hasegawa, D., Okudaira, T., Watanabe, K., Kato, H., Onda, T., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0754-4 · Cited by 35
“Furthermore, hiPSCs have different genetic backgrounds and could exhibit heterogeneity, thereby limiting their use as model systems [19].”
BackgroundVigilante, A., Laddach, A., Moens, N., Meleckyte, R., Leha, A., Ghahramani, A., Culley, O. J., Kathuria, A., Hurling, C., Vickers, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.094 · Cited by 34
“The concept that genetic background contributes to the variability of human iPSCs is supported by a number of earlier studies (Kyttälä et al., 2016; Burrows et al., 2016; Rouhani et al., 2014).”
ResultJang, S. E., Qiu, L., Chan, L. L., Tan, E., & Zeng, L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.558532 · Cited by 35
“It is crucial to take into consideration the wide genetic variation of iPSCs, which may harbor a large spectrum of genetic variation and even retain donor-specific gene expression pattern depending on multiple factors, such as the number of passages of the lineage or transcriptional factors introduced to induce cell d…”
BackgroundAddressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Biendarra‐Tiegs, S. M., Secreto, F. J., & Nelson, T. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_350 · Cited by 38
Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature
Thomas, S. M., Kagan, C. L., Pavlovic, B. J., Burnett, J. E., Patterson, K. M., Pritchard, J. K., & Gilad, Y. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005216 · Cited by 37
“Importantly, the genetic background of iPSCs generated from peripheral blood mononuclear cells and fibroblasts was recently demonstrated to account for more of the variation in gene expression between iPSC lines than any other tested factor such as cell type of origin or reprogramming method [20].”
BackgroundHuman induced pluripotent stem cells: A disruptive innovation
Vos, J. D., Bouckenheimer, J., Sansac, C., Lemaître, J.-M., & Assou, S. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.04.001 · Cited by 37
“Consequently, the buffering systems that may compensate the effects of genetic diversity in differentiation pathways also are defective [17].”
Background10th anniversary of iPS cells: the challenges that lie ahead
Aoi, T. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw044 · Cited by 36
Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells
Trevisan, M., Desole, G., Costanzi, G., Lavezzo, E., Palù, G., & Barzon, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010206 · Cited by 32
Systems-Wide Approaches in Induced Pluripotent Stem Cell Models
Lau, E., Paik, D. T., & Wu, J. C. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013046 · Cited by 34
Polit, L. D., Eidhof, I., McNeill, R. V., Warre-Cornish, K. M., Ohki, C. M. Y., Walter, N. M., Sala, C., Verpelli, C., Radtke, F., Galderisi, S., et al. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.101125 · Cited by 35
“Indeed, hiPSC clones of a single individual created from different somatic cell types, such as blood or skin, are more similar in their expression pro fi le than hiPSC-lines created from identical somatic cell types from different donors (Rouhani et al., 2014).”
Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges
Liu, L., & Zheng, Y. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i7.375 · Cited by 32
Evans, A., Dalby, A., Foster, H. R., Howard, D. J., Waller, A. K., Taimoor, M., Lawrence, M., Mookerjee, S., Lehmann, M., Burton, A. K., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003236 · Cited by 36
“of this molecular heterogeneity.(12-14) Predicting which hPSCs are likely to have a satisfactory terminally differentiated output or eliminating this variability remains one of the biggest challenges in the field, made even more crucial given the paucity of available clinical-grade cell lines and the cost of producing…”
BackgroundCapturing Human Naïve Pluripotency in the Embryo and in the Dish
Zimmerlin, L., Park, T. S., & Zambidis, E. T. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0055 · Cited by 38
“These studies employed both integrative and nonintegrative deri-vation methods for cellular reprogramming (eg, Sendai virus [120,170–172,174], A publication from the Progenitor Cell Biology Consortium analyzed a large repertoire of 58 hiPSC lines from 10 independent laboratories and reported a…”
Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells
Hoffmann, A., Ziller, M. J., & Spengler, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123829 · Cited by 32
Basic and Preclinical Research for Personalized Medicine
Lattanzi, W., Ripoli, C., Greco, V., Barba, M., Iavarone, F., Minucci, A., Urbani, A., Grassi, C., & Parolini, O. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050354 · Cited by 32
Ivanov, N. A., Tao, R., Chenoweth, J. G., Brandtjen, A. C., Mighdoll, M. I., Genova, J. D., McKay, R. D. G., Jia, Y., Weinberger, D. R., Kleinman, J. E., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005819 · Cited by 35
“Fibroblasts are one of the most popular cell types for generating iPSCs [12], particularly from skin, given the relative ease of access to these cells, although other skin-derived cell types such as keratinocytes from the same individual generate similar iPSC lines [13].”
BackgroundSomatic mutations alter the differentiation outcomes of iPSC-derived neurons
Puigdevall, P., Jerber, J., Danecek, P., Castellano, S., & Kilpinen, H. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100280 · Cited by 29
Ahmed, E., Sansac, C., Assou, S., Gras, D., Petit, A., Vachier, I., Chanez, P., Vos, J. D., & BOURDIN, A. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.002 · Cited by 37
Induced pluripotent stem cell‐based modeling of mutant LRRK 2‐associated Parkinson's disease
Weykopf, B., Haupt, S., Jungverdorben, J., Flitsch, L. J., Hebisch, M., Liu, G., Suzuki, K., Belmonte, J. C. I., Peitz, M., Blaess, S., et al. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14345 · Cited by 32
“Accordingly, iPSC lines generated from different donor tissues with the same genetic background showed a much higher similarity than iPSC lines from different donors (Kyttala et al., 2016; Rouhani et al., 2014).”
BackgroundEpigenetic Memory: Lessons From iPS Cells Derived From Human β Cells
Efrat, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.614234 · Cited by 37
“One of these studies (13) compared 25 iPSC lines from four donors and three tissues.”
BackgroundModeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs)
Noh, H., Shao, Z., Coyle, J. T., & Chung, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.019 · Cited by 29
“Development and refinement of iPSC technology so far allows reliable and robust reprogramming into hES-like cells with most of the variance among iPSCs derived from individual differences, not clonal line differences [76,77].”
BackgroundTownshend, R. F., Shao, Y., Wang, S., Cortez, C. L., Esfahani, S. N., Spence, J. R., O'Shea, K. S., Fu, J., Gumucio, D. L., & Taniguchi, K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.588941 · Cited by 33
Humanity in a Dish: Population Genetics with iPSCs
Warren, C. R., & Cowan, C. A. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.09.006 · Cited by 27
Schaniel, C., Dhanan, P., Hu, B., Xiong, Y., Raghunandan, T., Gonzalez, D. M., Dariolli, R., D'Souza, S. L., Yadaw, A. S., Hansen, J., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.10.005 · Cited by 26
“Nevertheless, such libraries have been used for the study of how genetic variants associated with complex genomic traits and phenotypes drive molecular and physiological variation in hiPSCs and their differentiated cells (Carcamo-Orive et al., 2017; D’Antonio-Chronowska et al., 2019; DeBoever et al., 2017; Karch et al…”
BackgroundShutova, M. V., Surdina, A. V., Ischenko, D. S., Naumov, V. A., Bogomazova, A. N., Vassina, E. M., Alekseev, D. G., Lagarkova, M. A., & Киселев, С. Л. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1152425 · Cited by 28
“It is now evident that differences in the quality of iPSC clones are largely due to technical variables relating to reprogramming approaches and culture conditions.(4,8,27,32) Additionally, some uncontrolled stochastic events during reprogramming undoubtedly influence gene expression and DNA methylation patterns in ev…”
BackgroundThurner, M., Shenhav, L., Wesolowska‐Andersen, A., Bennett, A. J., Barrett, A., Gloyn, A. L., McCarthy, M. I., Beer, N. L., & Efrat, S. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.020 · Cited by 27
“Differentiation efficiency also varies across iPSC lines (Bar-Nur et al., 2011; Burrows et al., 2016; Kim et al., 2010; Kyttala et al., 2016; Polo et al., 2010; Rouhani et al., 2014).”
BackgroundInfluentialMcCaughey, T., Chen, C. Y., Smit, E. D., Rees, G., Fenwick, E., Kearns, L. S., Mackey, D. A., MacGregor, C., Munsie, M., Cook, A. L., et al. (2016) · Cell and Tissue Banking · doi:10.1007/s10561-016-9563-8 · Cited by 26
Advances in Reprogramming-Based Study of Neurologic Disorders
Nityanandam, A., & Baldwin, K. K. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0044 · Cited by 31
“recently showed that the influence of epigenetic memory on the transcription profile of an iPSC line is minimal; in comparison, the genetic background of the individuals these lines are derived from contribute to greater heterogeneity in neural differentiation assays [125].”
Epigenetic Mechanisms of ART-Related Imprinting Disorders: Lessons From iPSC and Mouse Models
Horánszky, A., Becker, J. L., Zana, M., Ferguson‐Smith, A. C., & Dinnyés, A. (2021) · Genes · doi:10.3390/genes12111704 · Cited by 28
Modelling urea cycle disorders using iPSCs
Duff, C. E., & Baruteau, J. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00252-5 · Cited by 27
Tsuchida, N., Kojima, J., Fukuda, A., Oda, M., Kawasaki, T., Ito, H., Kuji, N., Isaka, K., Nishi, H., Umezawa, A., et al. (2019) · Placenta · doi:10.1016/j.placenta.2019.10.006 · Cited by 24
Superhuman cell death detection with biomarker-optimized neural networks
Linsley, J. W., Linsley, D. A., Lamstein, J., Ryan, G., Shah, K. D., Castello, N. A., Oza, V. D., Kalra, J., Wang, S., Tokuno, Z., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf8142 · Cited by 31
Systematic assessment of variability in the proteome of iPSC derivatives
Beekhuis-Hoekstra, S. D., Watanabe, K., Werme, J., de Leeuw, C. A., Paliukhovich, I., Li, K. W., Koopmans, F., Smit, A. B., Posthuma, D., & Heine, V. M. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102512 · Cited by 23
Ishikawa, T., Kobayashi, M., Yanagi, S., Kato, C., Takashima, R., Kobayashi, E., Hagiwara, K., & Ochiya, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123193 · Cited by 23
“Donor differences in hiPSC generation are considered to be an important determinant of the propensity for differentiation and the transcriptional variation between their lines [12, 38].”
BackgroundNuclear Reprogramming by Defined Factors: Quantity Versus Quality
Sebban, S., & Buganim, Y. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.08.006 · Cited by 24
Bridging the translational gap: what can synaptopathies tell us about autism?
Molloy, C. J., Cooke, J., Gatford, N. J. F., Rivera-Olvera, A., Avazzadeh, S., Homberg, J. R., Grandjean, J., Fernandes, C., Shen, S., Loth, E., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1191323 · Cited by 26
van de Bunt, M., Lako, M., Barrett, A., Gloyn, A. L., Hansson, M. D., McCarthy, M. I., Beer, N. L., & Honoré, C. (2016) · Islets · doi:10.1080/19382014.2016.1182276 · Cited by 26
Modeling myeloid malignancies with patient-derived iPSCs
Papapetrou, E. P. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.11.006 · Cited by 24
Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons
Chlebanowska, P., Sułkowski, M., Skrzypek, K., Tejchman, A., Muszyńska, A., Noroozi, R., & Majka, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165705 · Cited by 26
“On the other hand, there are also manuscripts suggesting that epigenetic memory has no impact on the generation of iPS cell lines from different cell origins [38], or indicating no impact of iPS origin on 2D differentiation to neuronal progenitor cells [39], so further research on that subject is still required.”
BackgroundShum, C., Macedo, S. C., Warre-Cornish, K. M., Cocks, G. D., Price, J., & Srivastava, D. P. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.06.014 · Cited by 27
“These findings suggest that iPSC-based studies should focus on working with iPSC lines from different donors rather than multiple lines derived from the same individual (Rouhani et al., 2014).”
BackgroundInfluentialGilmore, R. B., Liu, Y., Stoddard, C. E., Chung, M. S., Carmichael, G., & Cotney, J. L. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1129 · Cited by 24
Making it stick: chasing the optimal stem cells for cardiac regeneration
Quijada, P. J., & Sussman, M. A. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.972941 · Cited by 24
“RNA-sequencing, transcriptional variation of iPSCs created from human fibroblasts correlate with the background of donors (age, disease, personal habits), although the overall phenotypic traits of human iPSCs are similar ex vivo [44].”
BackgroundFunctional Characterization of Genetic Variant Effects on Expression
Flynn, E. D., & Lappalainen, T. (2022) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-122120-010010 · Cited by 29
Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities
Lange, J., Zhou, H., & McTague, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.941528 · Cited by 23
Current status in cancer cell reprogramming and its clinical implications
İzgi, K., Canatan, H., & İskender, B. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2258-5 · Cited by 24
Proteasome impairment in neural cells derived from HMSN-P patient iPSCs
Murakami, N., Imamura, K., Izumi, Y., Egawa, N., Tsukita, K., Enami, T., Yamamoto, T., Kawarai, T., Kaji, R., & Inoue, H. (2017) · Molecular Brain · doi:10.1186/s13041-017-0286-y · Cited by 23
“We analyzed mRNA expression levels of each of the iPSC clones using RNA-seq analysis, and confirmed that the significant differences were not observed among iPSCs generated from human dermal fibroblasts (HDFs) and iPSCs generated from peripheral blood mononuclear cells (PBMCs) (Additional file 1: Figure S1B), as shown…”
MethodKim, S., Seo, S., Stein-O’Brien, G., Jaishankar, A., Ogawa, K., Micali, N., Luria, V., Karger, A., Wang, Y., Kim, H., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.07.004 · Cited by 20
Qiu, Y., Wang, H., Fan, M., Pan, H., Guan, J., Jiang, Y., Jia, Z., Wu, K., Zhou, H., Zhuang, Q., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05899-6 · Cited by 23
“As previously reported, the diversity of genetic backgrounds in different donors may cause iPSC heterogeneity [44, 45].”
Sawada, T., Barbosa, A. R., Araújo, B. H. S., McCord, A. E., D’Ignazio, L., Benjamin, K. J., Sheehan, B., Zabolocki, M., Feltrin, A. S., Arora, R., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220723 · Cited by 23
An ancestry‐based approach for detecting interactions
Park, D. S., Eskin, I., Kang, E. Y., Gamazon, E. R., Eng, C. S., Gignoux, C. R., Galanter, J., Burchard, E. G., Ye, C., Aschard, H., et al. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22087 · Cited by 22
“There is growing evidence that both genegene and gene-environment interactions contribute significantly to phenotypic variation in humans and model organisms[1-5].”
BackgroundResultMechanosensitivity of Human Oligodendrocytes
Espinosa-Hoyos, D., Burstein, S. R., Cha, J., Jain, T., Nijsure, M. P., Jagielska, A., Fossati, V., & Vliet, K. J. V. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00222 · Cited by 21
“, 2007) have enabled the production of all major human CNS cell types, carrying the genetic information of the donors (Dolmetsch and Geschwind, 2011; Rouhani et al., 2014; Goldman and Kuypers, 2015; Carcamo-Orive et al., 2017; Elitt et al., 2018; Zheng et al., 2018).”
BackgroundMethodRoccio, M. (2020) · Stem Cells · doi:10.1002/stem.3315 · Cited by 21
“genetic background has been identified as a major factor introducing variability in the differentiation outcome across iPSC lines.(160,161)”
BackgroundCao, D., Ge, J.-Y., Wang, Y., Oda, T., & Zheng, Y. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4784 · Cited by 19
Deafness-in-a-dish: modeling hereditary deafness with inner ear organoids
Romano, D. R., Hashino, E., & Nelson, R. F. (2021) · Human Genetics · doi:10.1007/s00439-021-02325-9 · Cited by 18
“However, several studies have revealed the presence of significant genetic background variation among iPSCs, which, in turn, leads to significant variability in the directed differentiation process (Burrows et al. 2016; Kyttala et al. 2016; Rouhani et al. 2014).”
BackgroundLange, J., Wood‐Kaczmar, A., Ali, A., Farag, S. H., Ghosh, R., Parker, J., Casey, C. S., Uno, Y., Kunugi, A., Ferretti, P., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.742763 · Cited by 20
Panova, A. V., Klementieva, N. V., Sycheva, A. V., Korobko, E. V., Sosnovtseva, A. O., Krasnova, T. S., Karpova, M. R., Рубцов, П. М., Tikhonovich, Y. V., Tiulpakov, A. N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158824 · Cited by 20
Rovina, D., Castiglioni, E., Niro, F., Mallia, S., Pompilio, G., & Gowran, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196997 · Cited by 18
Cho, Y. K., Kim, H.-K., Kwon, S. S., Jeon, S.-H., Cheong, J., Nam, K. T., Kim, S., Kim, S., & Kim, H. O. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03305-8 · Cited by 18
“Contradictory findings that suggest epigenetic memory has minimal effects on differentiation have also been reported [43, 44].”
BackgroundModeling Disease with Human Inducible Pluripotent Stem Cells
Grandy, R. A., Tomaz, R. A., & Vallier, L. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043634 · Cited by 22
Self-citationOvchinnikov, D. A., Withey, S., Leeson, H. C., Lei, B. U. W., Sundarrajan, A., Junday, K., Pewarchuk, M. E., Yeo, A. J., Kijas, A. W., Lavin, M. F., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa023 · Cited by 18
Manipulating cell fate through reprogramming: approaches and applications
Yagi, M., Horng, J. E., & Hochedlinger, K. (2024) · Development · doi:10.1242/dev.203090 · Cited by 17
Mishra, S., Kaçin, E., Stamatiadis, P., Franck, S., der Jeught, M. V., Mertes, H., Pennings, G., Sutter, P. D., Sermon, K., Heindryckx, B., et al. (2018) · Molecular Human Reproduction · doi:10.1093/molehr/gay007 · Cited by 18
“…hiPSC can be explained by inter-individual genetic variation (Boulting et al., 2011; Kajiwara et al., 2012; Mills et al., 2013; Nasu et al., 2013; Rouhani et al., 2014; Choi et al., 2015; Burrows et al., 2016; Salomonis et al., 2016; Kyttälä et al., 2016; Nishizawa et al., 2016; Carcamo-Orive et…”
Hawkins, K., & Duchen, M. R. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i5.236 · Cited by 18
From the Psychiatrist’s Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish
Hoffmann, A., Sportelli, V., Ziller, M. J., & Spengler, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030770 · Cited by 19
Hübner, D., Jahn, K., Pinkert, S., Böhnke, J., Jung, M., Fechner, H., Rujescu, D., Liebert, U. G., & Claus, C. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00103 · Cited by 16
Winiecka-Klimek, M., Smolarz, M., Walczak, M. P., Zięba, J., Hułas-Bigoszewska, K., Kmieciak, B., Piaskowski, S., Rieske, P., Grzela, D. P., & Stoczyńska-Fidelus, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141688 · Cited by 17
“It has also been reported that iPSCs show line-to-line variability [49] what may influence their differentiation potency [50,51].”
BackgroundIacovides, D. C., Rizki, G., Lapathitis, G., & Strati, K. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0357-5 · Cited by 20
“Furthermore, some transcriptome variation also exists among populations of the same type of cells [26].”
BackgroundEdenhofer, F. C., Térmeg, A., Ohnuki, M., Jocher, J., Kliesmete, Z., Briem, E., Hellmann, I., & Enard, W. (2024) · iScience · doi:10.1016/j.isci.2024.110090 · Cited by 19
“Hence, variable expression levels of KRAB-dCas9 and additionally the well-known variability among clones, 69,70 individuals, and species, would still require to screen or at least validate results from CRISPRi screens in a sufficient number of cell lines to generalize findings within a species and…”
What we can learn from iPSC-derived cellular models of Parkinson's disease
Caiazza, M. C., Lang, C., & Wade‐Martins, R. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.11.002 · Cited by 18
Boyling, A., Pérez‐Siles, G., & Kennerson, M. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.842860 · Cited by 16
“Donor genetic background accounts for most of the variability observed between iPSC lines (Kajiwara et al., 2012; Rouhani et al., 2014; Kyttälä et al., 2016), and can be avoided through the use of isogenic controls.”
BackgroundEvaluation of inter-batch differences in stem-cell derived neurons
Morrison, G., Liu, C., Wing, C., Delaney, S. M., Zhang, W., & Dolan, M. E. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.12.025 · Cited by 17
“…demonstrated that the genetic background of iPSCs generated from peripheral blood mononuclear cells or fibroblasts accounted for more of the variation in gene expression between iPSC lines than any other tested factors such as cell type of origin or reprogramming method (Rouhani et al., 2014).”
BackgroundMethodInfluentialMapping regulatory variants in hiPSC models
Hoffman, G. E., & Brennand, K. (2017) · Nature Genetics · doi:10.1038/s41588-017-0017-4 · Cited by 15
Faravelli, I., Antón-Bolaños, N., Brown, J. R., & Arlotta, P. (2025) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-111522-014009 · Cited by 18
Susco, S. G., Ghosh, S. D., Mazzucato, P., Angelini, G., Beccard, A., Barrera, V., Berryer, M. H., Messana, A., Lam, D., Hazelbaker, D. Z., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111312 · Cited by 15
“Based on data from large-scale hPSC studies indicating that increasing the number of independent genetic backgrounds addsmore value than clonal replicates from a smaller set of backgrounds (Germain and Testa, 2017; Hoffman et al., 2019; Rouhani et al., 2014), combinedwith the significant heterogeneity reported among p…”
Benazzato, C., Lojudice, F. H., Pöehlchen, F., Leite, P. E. C., Manucci, A. C., van der Linden, V., Jungmann, P., Sogayar, M. C., Bruni‐Cardoso, A., Russo, F. B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65392-8 · Cited by 16
“…to neurodevelopmental disorders, rare diseases, and diseases related to epigenetics and mutations, since this technology can retain the donor cells’ genetic background, gene expression and even genetic changes caused by epigenetic effects accounted for in a cell, under cell reprogramming 16,17 .”
Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering
Jung, M., Dunbar, C. E., & Winkler, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.180 · Cited by 16
Jacobson, E. F., & Tzanakakis, E. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1109-y · Cited by 14
Cao, L., van der Meer, A. D., Verbeek, F. J., & Passier, R. C. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3466-1 · Cited by 16
Harnessing pluripotent stem cells as models to decipher human evolution
Dannemann, M., & Romero, I. G. (2021) · FEBS Journal · doi:10.1111/febs.15885 · Cited by 14
Reibetanz, U., Hübner, D., Jung, M., Liebert, U. G., & Claus, C. (2016) · ACS Nano · doi:10.1021/acsnano.6b00999 · Cited by 14
“(2) The application of LbL carriers before (reverse approach) or after (direct approaches) iPSC”
Incomplete reprogramming of DNA replication timing in induced pluripotent stem cells
Edwards, M. M., Wang, N., Massey, D. J., Bhatele, S., Egli, D. M., & Koren, A. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113664 · Cited by 13
“16 Similarly, some genes, such as TCERG1L, show consistent DNA methylation differences between ESCs and iPSCs.”
BackgroundSrijaya, T. C., Sriram, S., Subramanian, S., Cheng, S., Ong, W. K., Rozen, S., Kasim, N. H. A., & Sugii, S. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0796-2 · Cited by 13
“introduce such variability in iPS cells [33, 34].”
CRISPR-based functional evaluation of schizophrenia risk variants
Rajarajan, P., Flaherty, E. K., Akbarian, S., & Brennand, K. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.017 · Cited by 14
Bjørlykke, Y., Søviknes, A. M., Hoareau, L., Vethe, H., Mathisen, A. F., Chera, S., Vaudel, M., Ghila, L., & Ræder, H. (2019) · Stem Cells International · doi:10.1155/2019/8036035 · Cited by 14
“Also, variation in hiPSC lines has been shown to be donor dependent [5, 44, 45]; our studies, however, showed that variations related to colony morphology are not donor dependent, as three of the donors (donors 3, 4, and 6) had lines classified to more than one morphology group.”
ResultModeling tau pathology in human stem cell derived neurons
Wray, S. (2017) · Brain Pathology · doi:10.1111/bpa.12521 · Cited by 16
The cancer's gone, but did chemotherapy damage your heart?
Bellin, M., & Mummery, C. L. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.88 · Cited by 13
Krasnova, O. A., Gursky, V. V., Chabina, A. S., Kulakova, K. A., Lp, A., Panova, A. V., Киселев, С. Л., & Neganova, I. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112902 · Cited by 13
Eade, K., Ansell, B. R. E., Giles, S., Fallon, R. J., Harkins-Perry, S. R., Nagasaki, T., Tzaridis, S., Wallace, M., Mills, E. A., Farashi, S., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163771 · Cited by 13
Capturing the ephemeral human pluripotent state
Ávila‐González, D., García-López, G., García‐Castro, I. L., Flores‐Herrera, H., Molina‐Hernández, A., Portillo, W., & Díaz, N. F. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24405 · Cited by 12
“Thus, Rouhani et al. reported that genetic differences of donor cells have a major impact in the transcriptional variation of hiPSC, while their epigenetic memory has a minimal contribution to hiPSC heterogeneity (Rouhani et al., 2014).”
BackgroundBeer, N. L., & Gloyn, A. L. (2016) · F1000Research · doi:10.12688/f1000research.8682.1 · Cited by 13
Pan-Genomic Regulation of Gene Expression in Normal and Pathological Human Placentas
Apicella, C., Ruano, C. S. M., Thilaganathan, B., Khalil, A. A., Giorgione, V., Gascoin-Lachambre, G., Marcellin, L., Gaspar, C., Jacques, S., Murdoch, C. E., et al. (2023) · Cells · doi:10.3390/cells12040578 · Cited by 13
“Therefore, the RV is a measure of potential genetic influence on gene expression levels, amongst other variables [26,27].”
BackgroundPluripotent cell states and fates in human embryo models
Sözen, B., Tam, P., & Pera, M. F. (2025) · Development · doi:10.1242/dev.204565 · Cited by 12
PFOS disrupts key developmental pathways during hiPSC-derived cardiomyocyte differentiation in vitro
Davidsen, N., Ramhøj, L., Kugathas, I., Evrard, B., Darde, T., Chalmel, F., Svingen, T., & Rosenmai, A. K. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105475 · Cited by 9
Zhang, Z., Zhang, J., Huang, S., He, X., & Deng, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01907-0 · Cited by 11
“iPSCs are heterogeneous and highly diverse compared to ESCs due to epigenetic memory [61, 62] and epigenetic dynamics [63], which exhibit features of incomplete reprogramming and present limitations in disease modeling and personalized medicine [64].”
BackgroundPopulation-scale proteome variation in human induced pluripotent stem cells
Mirauta, B. A., Seaton, D. D., Bensaddek, D., Brenes, A., Bonder, M. J., Kilpinen, H., HipSci Consortium, Stegle, O., & Lamond, A. I. (2018) · doi:10.1101/439216 · Cited by 10
Metzler, E., Escobar, H., Sunaga, D. Y., Sauer, S., Diecke, S., & Spuler, S. (2022) · Biomedicines · doi:10.3390/biomedicines10051204 · Cited by 9
iPSC-Derived Corneal Endothelial Cells
Zhou, Q., Li, Z., & Duan, H. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_644 · Cited by 9
Tsifaki, M., Kelaini, S., Caines, R., Yang, C., & Margariti, A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00109 · Cited by 9
“The cause of that variability is most probably due to the parental line or even disease-specific mutations, therefore, making it clear that the genetic background is crucial to the differentiation potential of a donor-line; curiously surpassing even that of the source-specific variation (29, 30).”
BackgroundVickers, A., Zandstra, P. W., Laddach, A., Poletti, M., Salameti, V., Fraternali, F., Danovi, D., & Watt, F. M. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.09.017 · Cited by 9
“Studies based on multiple iPSC lines from the same donor, different reprogramming methods, and isogenic iPSC lines from different source cell types have often found that the genetic background of the donor is a major contributor to iPSC variability (Bock et al., 2011; Burrows et al., 2016; Rouhani et al., 2014).”
Background
Metadata
- Authors
- Rouhani, F., Kumasaka, N., de Brito, M. C., Bradley, A., Vallier, L., & Gaffney, D.
- Affiliations
- Wellcome Sanger Institute (GB)
- University of Cambridge (GB)
- Corresponding author
- Gaffney, Daniel
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-05
- Volume
- 10
- Issue
- 6
- Pages
- e1004432
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC4046971
- OpenAlex
- W2008485310
- Cited by
- 294
- References
- 35
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 22 · 2023: 22 · 2022: 19 · 2021: 29 · 2020: 25 · 2019: 21 · 2018: 33 · 2017: 37 · 2016: 33 · 2015: 25 · 2014: 5
- FWCI
- 13.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Wellcome Trust (EU-FP7-, 098051)
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- National Institute for Health and Care Research
- Engineering and Physical Sciences Research Council (TS/H001220/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- human induced pluripotent stem cells, transcriptional heterogeneity, epigenetic memory, cell line heterogeneity, disease modeling, personalized medicine
- MeSH terms
- Adult, Base Sequence, Cell Differentiation, Cells, Cultured, Female, Fibroblasts, Humans, Male, Transcription, Genetic, Keratinocytes, Sequence Alignment, Sequence Analysis, RNA, Endothelial Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.